Bindley Capital Partners I, LLC
CIK: 0002038820
Associated companies
Transaction History
| GRDN | ▲ Buy | Option Exercise | 6,100,175 | — | 9/27/2026 | View on chart |
| GRDN | ▲ Buy | Option Exercise | 6,100,175 | — | 3/28/2026 | View on chart |
| GRDN | ▼ Sell | Open Market | 3,570,677 | $106.0M | 3/20/2026 | View on chart |
| GRDN | ▲ Buy | Option Exercise | 6,100,176 | — | 9/27/2025 | View on chart |
| GRDN | ▼ Sell | Open Market | 651,454 | $13.1M | 5/28/2025 | View on chart |
| GRDN | ▼ Sell | Open Market | 3,508,905 | $70.7M | 5/27/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Guardian Pharmacy Services Q2 2026 Earnings Call Highlights
Guardian Pharmacy Services held its Q2 2026 earnings conference call, reviewing the quarter’s financial results and outlook. Management addressed performance metrics and future expectations, offering insight for investors. The discussion comes as the stock trades near its recent support level of $40.33, with an RSI around 40, indicating modest momentum.
Guardian Pharmacy Services Q2 2026 Earnings Call Highlights. Guardian Pharmacy Services held its Q2 2026 earnings conference call, reviewing the quarter’s financial results and outlook. Management addressed performance metrics and future expectations, offering insight for investors. The discussion comes as the stock trades near its recent support level of $40.33, with an RSI around 40, indicating modest momentum.